A mechanism for localized dynamics-driven activation in Bruton's tyrosine kinase

被引:2
作者
Qiu, Simei [1 ,2 ]
Liu, Yunfeng [1 ]
Li, Quhuan [1 ,2 ,3 ]
机构
[1] South China Univ Technol, Inst Biomech, Sch Biosci & Bioengn, Guangzhou, Peoples R China
[2] South China Univ Technol, Guangdong Prov Engn & Technol Res Ctr Biopharmace, Guangzhou, Peoples R China
[3] South China Univ Technol, Sch Biosci & Bioengn, Guangzhou 510006, Guangdong, Peoples R China
来源
ROYAL SOCIETY OPEN SCIENCE | 2021年 / 8卷 / 08期
基金
中国国家自然科学基金;
关键词
activation mechanism; Bruton's tyrosine kinase; T474M mutation; X-LINKED AGAMMAGLOBULINEMIA; IRREVERSIBLE INHIBITORS; TARGETING BTK; IBRUTINIB; DISCOVERY; MUTATION; PATHWAY; BINDING; CANCER; CELLS;
D O I
10.1098/rsos.210066
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Bruton's tyrosine kinase (BTK) plays a vital role in mature B-cell proliferation, development and function. Its inhibitors have gradually been applied for the treatment of many B-cell malignancies. However, because of treatment-associated drug resistance or low efficacy, it is urgent to develop new inhibitors and/or improve the efficacy of current inhibitors, where finding the intrinsic activation mechanism becomes the key to solve this problem. Here, we used BTK T474M mutation as a resistance model for inhibitors to study the mechanism of BTK activation and drug resistance by free molecular dynamics simulations. The results showed that the increase of kinase activity of T474M mutation is coming from the conformation change of the activation ring and ATP binding sites located in BTK N-terminus region. Specifically, the Thr(474) mutation changed the structure of A-loop and stabilized the binding site of ATP, thus promoting the catalytic ability in the kinase domain. This localized dynamics-driven activation mechanism and resistance mechanism of BTK may provide new ideas for drug development in B-cell malignancies.
引用
收藏
页数:11
相关论文
共 42 条
  • [1] Lipid-targeting pleckstrin homology domain turns its autoinhibitory face toward the TEC kinases
    Amatya, Neha
    Wales, Thomas E.
    Kwon, Annie
    Yeung, Wayland
    Joseph, Raji E.
    Fulton, D. Bruce
    Kannan, Natarajan
    Engen, John R.
    Andreotti, Amy H.
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2019, 116 (43) : 21539 - 21544
  • [2] Ibrutinib as Initial Therapy for Patients with Chronic Lymphocytic Leukemia
    Burger, J. A.
    Tedeschi, A.
    Barr, P. M.
    Robak, T.
    Owen, C.
    Ghia, P.
    Bairey, O.
    Hillmen, P.
    Bartlett, N. L.
    Li, J.
    Simpson, D.
    Grosicki, S.
    Devereux, S.
    McCarthy, H.
    Coutre, S.
    Quach, H.
    Gaidano, G.
    Maslyak, Z.
    Stevens, D. A.
    Janssens, A.
    Offner, F.
    Mayer, J.
    O'Dwyer, M.
    Hellmann, A.
    Schuh, A.
    Siddiqi, T.
    Polliack, A.
    Tam, C. S.
    Suri, D.
    Cheng, M.
    Clow, F.
    Styles, L.
    James, D. F.
    Kipps, T. J.
    Keating, Michael
    Jen, Jie
    Jindra, Pavel
    Simkovic, Martin
    Braester, Andrei
    Ruchlemer, Rosa
    Foa, Roberto
    Semenzato, Gianpietro
    Hawkins, Timothy
    Atanasio, Carolina Moreno
    Demirkan, Fatih
    Kaynar, Leylagul
    Pylypenko, Halyna
    Fox, Christopher
    Thirman, Michael
    Campbell, Philip
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (25) : 2425 - 2437
  • [3] Acalabrutinib (ACP-196) in Relapsed Chronic Lymphocytic Leukemia
    Byrd, John C.
    Harrington, Bonnie
    O'Brien, Susan
    Jones, Jeffrey A.
    Schuh, Anna
    Devereux, Steve
    Chaves, Jorge
    Wierda, William G.
    Awan, Farrukh T.
    Brown, Jennifer R.
    Hillmen, Peter
    Stephens, Deborah M.
    Ghia, Paolo
    Barrientos, Jacqueline C.
    Pagel, John M.
    Woyach, Jennifer
    Johnson, Dave
    Huang, Jane
    Wang, Xiaolin
    Kaptein, Allard
    Lannutti, Brian J.
    Covey, Todd
    Fardis, Maria
    McGreivy, Jesse
    Hamdy, Ahmed
    Rothbaum, Wayne
    Izumi, Raquel
    Diacovo, Thomas G.
    Johnson, Amy J.
    Furman, Richard R.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2016, 374 (04) : 323 - 332
  • [4] Molecular basis for receptor tyrosine kinase A-loop tyrosine transphosphorylation
    Chen, Lingfeng
    Marsiglia, William M.
    Chen, Huaibin
    Katigbak, Joseph
    Erdjument-Bromage, Hediye
    Kemble, David J.
    Fu, Lili
    Ma, Jinghong
    Sun, Gongqin
    Zhang, Yingkai
    Liang, Guang
    Neubert, Thomas A.
    Li, Xiaokun
    Traaseth, Nathaniel J.
    Mohammadi, Moosa
    [J]. NATURE CHEMICAL BIOLOGY, 2020, 16 (03) : 267 - +
  • [5] Dynamic Allostery Mediated by a Conserved Tryptophan in the Tec Family Kinases
    Chopra, Nikita
    Wales, Thomas E.
    Joseph, Raji E.
    Boyken, Scott E.
    Engen, John R.
    Jernigan, Robert L.
    Andreotti, Amy H.
    [J]. PLOS COMPUTATIONAL BIOLOGY, 2016, 12 (03)
  • [6] Switch-like activation of Bruton's tyrosine kinase by membrane-mediated dimerization
    Chung, Jean K.
    Nocka, Laura M.
    Decker, Aubrianna
    Wang, Qi
    Kadlecek, Theresa A.
    Weiss, Arthur
    Kuriyan, John
    Groves, Jay T.
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2019, 116 (22) : 10798 - 10803
  • [7] Discovery of GDC-0853: A Potent, Selective, and Noncovalent Bruton's Tyrosine Kinase Inhibitor in Early Clinical Development
    Crawford, James J. y
    Johnson, Adam R.
    Misner, Dinah L.
    Belmont, Lisa D.
    Castanedo, Georgette
    Choy, Regina
    Coraggio, Melis
    Doug, Liming
    Eigenbrot, Charles
    Erickson, Rebecca
    Ghilardi, Nico
    Hau, Jonathan
    Katewa, Arna
    Kohli, Pawan Bir
    Lee, Wendy
    Lubach, Joseph W.
    McKenzie, Brent S.
    Ortwine, Daniel F.
    Schutt, Leah
    Tay, Suzanne
    Wei, BinQing
    Reif, Karin
    Liu, Lichuan
    Wong, Harvey
    Young, Wendy B.
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2018, 61 (06) : 2227 - 2245
  • [8] Mapping Paratope on Antithrombotic Antibody 6B4 to Epitope on Platelet Glycoprotein Ibalpha via Molecular Dynamic Simulations
    Fang, Xiang
    Fang, Ying
    Liu, Li
    Liu, Guangjian
    Wu, Jianhua
    [J]. PLOS ONE, 2012, 7 (07):
  • [9] Establishing a chemical genetic link between Bruton tyrosine kinase activity in malignant B cells and cell functions involved in the micro-environmental dialogue
    Goeckeritz, Elisa
    Vondey, Verena
    Guastafierro, Anna
    Pizevska, Maja
    Hassenrueck, Floyd
    Neumann, Lars
    Hallek, Michael
    Krause, Guenter
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2017, 178 (06) : 949 - 953
  • [10] Targeting cancer with kinase inhibitors
    Gross, Stefan
    Rahal, Rami
    Stransky, Nicolas
    Lengauer, Christoph
    Hoeflich, Klaus P.
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2015, 125 (05) : 1780 - 1789